Cognito Therapeutics vs Oryon Cell Therapies
Cognito Therapeutics vs Oryon Cell Therapies, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cognito Therapeutics is on 50/100 and Oryon Cell Therapies on 62/100.
Where each one leads
Cognito Therapeutics
- agent readiness: 33/100 against 22/100
- funding raised: $213M against $21.0M
Oryon Cell Therapies
- our overall score: 62/100 against 50/100
At a glance
| Measure | Cognito Therapeutics | Oryon Cell Therapies |
|---|---|---|
| What it is | Developing a novel therapeutic approach for Alzheimer's disease. | Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders. |
| Category | Biotechnology, Medical Devices, Neuroscience, Healthcare | Biotechnology, Health, Neuroscience, Cell Therapy |
| Sells toBusiness model | B2B2C | B2B |
| Offering | Hardware | Services |
| Founded | 2011 | Not published |
| Headquarters | Boston, USA | Belmont, USA |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Cognito Therapeutics | Oryon Cell Therapies |
|---|---|---|
| Total funding | $213M | $21.0M |
| Latest round | Series C | Series A |
| Valuation | $487M | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Cognito Therapeutics | Oryon Cell Therapies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 50/100 | 62/100 |
| Traction | 40/100 | 38/100 |
| Team | 60/100 | Not published |
| Search visibility | 10/100 | 19/100 |
| Quality | 65/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (33/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 47/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Cognito Therapeutics | Oryon Cell Therapies |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Open source | Yes | No |
Cognito Therapeutics vs Oryon Cell Therapies: common questions
Which is better, Cognito Therapeutics or Oryon Cell Therapies?
On our 0-100 score Oryon Cell Therapies rates higher (62/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Cognito Therapeutics and Oryon Cell Therapies compare on the numbers?
Cognito Therapeutics leads on agent readiness (33/100 against 22/100), funding raised ($213M against $21.0M). Oryon Cell Therapies leads on our overall score (62/100 against 50/100).
Read the full Cognito Therapeutics review and pricing or the Oryon Cell Therapies review and pricing. You can also browse other Cognito Therapeutics alternatives we track.